These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Global regulatory reforms to promote equitable vaccine access in the next pandemic. Mahoney R; Hotez PJ; Bottazzi ME PLOS Glob Public Health; 2023; 3(10):e0002482. PubMed ID: 37851688 [TBL] [Abstract][Full Text] [Related]
7. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries. Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496 [TBL] [Abstract][Full Text] [Related]
8. A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016). Palkonyay L; Fatima H Vaccine; 2016 Oct; 34(45):5414-5419. PubMed ID: 27498212 [TBL] [Abstract][Full Text] [Related]
9. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models. Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484 [TBL] [Abstract][Full Text] [Related]
10. Pandemic preparedness and response: beyond the Access to COVID-19 Tools Accelerator. Saxena A; Baker BK; Banda A; Herlitz A; Miller J; Karrar K; Fleurbaey M; Chiwa E; Atuire CA; Hirose I; Hassoun N BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36650015 [TBL] [Abstract][Full Text] [Related]
11. Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases. Mao W; Zimmerman A; Urli Hodges E; Ortiz E; Dods G; Taylor A; Udayakumar K BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37696544 [TBL] [Abstract][Full Text] [Related]
12. Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response. Braimoh T; Burrone E; Gore C; Vijayaraghavan P Global Health; 2024 Jul; 20(1):52. PubMed ID: 38956614 [TBL] [Abstract][Full Text] [Related]
13. Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics. Martin R; Maleche A; Gay J; Fatima H BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38167259 [TBL] [Abstract][Full Text] [Related]
14. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together. Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616 [TBL] [Abstract][Full Text] [Related]
15. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. Chandler RE; Balakrishnan MR; Brasseur D; Bryan P; Espie E; Hartmann K; Jouquelet-Royer C; Milligan J; Nesbitt L; Pal S; Precioso A; Takey P; Chen RT; BMJ Glob Health; 2024 Mar; 9(3):. PubMed ID: 38453518 [TBL] [Abstract][Full Text] [Related]
16. Factors, enablers and challenges for COVID-19 vaccine development. Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195 [TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473 [TBL] [Abstract][Full Text] [Related]
18. Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Graham JE; Borda-Rodriguez A; Huzair F; Zinck E Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930 [TBL] [Abstract][Full Text] [Related]